ANDREA FROESE: Open Payments
NPI 1952705592 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$993 in 40 payments from 14 companies in 2025. Trend: 2023 $1,332 · 2024 $1,127 · 2025 $993
Food & beverage: $948Education: $45
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $186 |
| Amgen Inc. | 3 | $162 |
| Lilly USA, LLC | 5 | $125 |
| PFIZER INC. | 5 | $82 |
| ABBVIE INC. | 3 | $65 |
| Astellas Pharma US Inc | 3 | $62 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| Gilead Sciences, Inc. | 2 | $51 |
| Exact Sciences Corporation | 3 | $48 |
| Novartis Pharmaceuticals Corporation | 2 | $45 |
Products named: Ozempic, TEZSPIRE, NURTEC ODT, MOUNJARO, Veozah, The Cologuard Plus Collection Kit, LEQVIO, QULIPTA.
Industry payments across MO — which companies pay providers there.
